Home
About IBT
IBT History
Management
Board of Directors
Advisory Board
Sustainability Policy
Pipeline
IBP-9414
IBP-1016
IBP-1118
IBP-1122
Families
Healthcare Professionals
Investors & Media
Shares
Presentations
Share Issue
Ownership Structure
Corporate Governance
Calendar
Financial Reports
Press Releases
Investors & Media Contact
Subscribe
Contact Us
Career
En
Sv
Home
About IBT
IBT History
Management
Board of Directors
Advisory Board
Sustainability Policy
Pipeline
IBP-9414
IBP-1016
IBP-1118
IBP-1122
Families
Healthcare Professionals
Investors & Media
Shares
Presentations
Share Issue
Ownership Structure
Corporate Governance
Calendar
Financial Reports
Press Releases
Investors & Media Contact
Subscribe
Contact Us
Career
Press releases
IBT resolves on a rights issue
May 16, 2023
Read more
here
Latest press releases
2024-04-04 19:32
Major Milestone Achieved - Last Patient Enrolled in Infant Bacterial Therapeutics’ Phase 3 Study
Regulatory
MAR
2024-04-03 11:00
Notice of Annual General Meeting of Infant Bacterial Therapeutics
Regulatory
2024-03-25 22:00
Infant Bacterial Therapeutics AB publishes the Annual Report for 2023
Regulatory
2024-02-08 08:30
Infant Bacterial Therapeutics AB (publ), Interim report January 1-December 31, 2023
Regulatory
2023-11-10 08:30
Infant Bacterial Therapeutics AB (publ), Interim report January 1-September 30, 2023
Regulatory